Received Mar 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
they noticed symptoms/have an allergy to ingredient in COVID-19 vaccine; This is a spontaneous report received from a Consumer or other non HCP from medical information team. A male patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Peg 3350, reaction(s): "Allergy: PEG 3350", notes: PEG, 3350 or something; Miralax, reaction(s): "allergy to Miralax". The following information was reported: ALLERGY TO VACCINE (non-serious), outcome "unknown", described as "they noticed symptoms/have an allergy to ingredient in COVID-19 vaccine". Additional information: The patient received 3 doses. The patient had an allergy to ingredient in COVID-19 vaccine, clarified a PEG 3350 or something allergy, an allergy to MiraLAX (said the ingredient in Miralax was also in the vaccine). No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500063102 Same patient, product, different dose number and event;US-PFIZER INC-202500063399 Same patient, product, different dose number and event;